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LETTER TO THE EDITORReducing
Non-Anastomotic Biliary
Strictures in Donation
After Circulatory Death
Liver Transplantation:
Cold Ischemia Time
Matters!
To the Editor:
We were impressed to read about thebeneficial effect of preimplantation
Hypothermic Oxygenated PErfusion (HOPE)
on the outcome after transplantation of livers
donated after circulatory death (DCD).1 In an
internationally matched cohort study,
Dutkowski et al showed that HOPE reduces
postreperfusion graft injury and early allog-
raft dysfunction compared with conventional
static cold storage. Furthermore, HOPE was
associated with a lower incidence of ischemic
cholangiopathy, also called non-anastomotic
strictures (NAS), and 1-year graft survival.
Warm ischemia time (WIT) is cur-
rently widely accepted as a risk factor of
NAS,2–4 but recent findings suggest that
the detrimental effect of prolonged cold
ischemia time (CIT) on the biliary tree and
graft function should not be underesti-
mated.5–7 We wonder whether (part of)
the effect on NAS in the treatment group
might not be due to the very short CIT in
the HOPE livers and the observed difference
with the DCD control group [HOPE-DCD
3hours (188minutes) vs DCD 6.5 hours
(395minutes); P ¼ 0.01]. The authors report
overall graft and cholangiopathy-free graft
survival 1 year after transplantation, and Cox
regression was corrected for CIT. However,
as only 1 hazard ratio is given, it is not
clear to us that the HOPE effect on cholangi-
opathy-free graft survival in multivariate
regression was indeed independent of CIT.
Additionally, it would be valuable to know
whether CIT was also an independent factor
of NAS in this series, as that gives useful
information for current clinical practice in
which DCD livers are mostly still statically
cold stored.
We ask the question since we observed
NAS developing in our DCD recipients
despite very short asystolic WIT (defined
as the period of time between circulatory
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indeed other factors are at play. In a retro-
spective analysis of 61 DCD liver transplan-
tations performed in our institution between
2003 and 2013, we could show a considerable
role of CIT. Donor, recipient, operative, and
outcome data were compared between recip-
ients with NAS (NASþ) and those without
NAS (NAS). Backward stepwise logistic
regression was used to identify risk factors of
NAS developing within 1 year after trans-
plantation. Continuous data are expressed as
median [interquartile range (IQR)]. Analyses
were performed in SPSS 20.0, and P < 0.05
was considered significant. Thirteen out of
61 (21%) recipients developed NAS despite
short asystolic WIT [9minutes (8–11)] and
CIT [5.8 hours (5.1–7.1)], with the shortest
CIT being 3.9 hours. Asystolic WIT was
similar within the groups [NASþ 9.5minutes
(8–10) vs NAS 8minutes (8–10.5); P ¼
0.2]. Donor demographics did not differ with
the exception of higher donor risk index in
NASþ [3 (2.9–3.5) vs 2.7 (2.4–3.1); P ¼
0.03]. No difference in recipient age, sex,
indication for transplantation, Lab Model for
End Stage Liver Disease (MELD) score
[NASþ 14 (11–18) vs NAS 15 (12–20);
P ¼ 0.8] or Balance of Risk (BAR) score
[NASþ 2 (2–4) vs NAS 2 (2–4); P ¼ 0.9]
was observed. NASþ had longer CIT
[7.3 hours (5.95–8.5) vs 5.6 hours (4.97–
6.75); P ¼ 0.004] and implantation
time [55minutes (46.5–60.5) vs 46minutes
(42–52.5); P ¼ 0.04]. In multivariable
regression, corrected for asystolic WIT and
implantation time, only CIT was associated
with NAS [odds ratio (OR) 1.62, 95% con-
fidence interval (CI) 1.08–2.4, P¼ 0.02).We
could identify a cut-off of 5 hours CIT as
the best predictor of NAS with 100% sensi-
tivity and 75% specificity (c-statistic of the
receiver operator characteristic curve: 0.76,
95% CI 0.63–0.896, P ¼ 0.004). Our data
confirm that limiting the duration of
CIT reduces the risk to develop NAS. In
our experience and in line with previous
research,8 no biliary complications were
observed in 12 recipients of DCD grafts with
CIT less than 5 hours. In the series by
Dutkowski et al, the upper quartile of CIT
in HOPE-treated livers was 4.4 hours
(264minutes), hence almost all livers were
exposed to CITof less than 5 hours. With this
premise, it is not unthinkable that DCD livers
perfused with HOPE may have suffered a
milder biliary injury, reducing the pretreat-
ment probability of developing NAS. It willMonth 2016
er Health, Inc. Unauthorized repongoing multicenter randomized controlled
trial in the DCD population (NCT02584283),
where CITs are likely to be longer, because
not all HOPE-treated grafts will be procured
locally like in the study by Dutkowski et al.
We congratulate the authors on their
pioneering work and thank them for any
additional data they may wish to share.
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